PCOS Weightloss: A Supportive Guide to Losing Weight With PCOS (Without Fighting Your Body) MyOva

PMOS (PCOS) Weight Loss: What the Research Says

You're not imagining it. If you have PMOS (PCOS) and you've felt like your body plays by different rules, you may be onto something. Research does link the condition with higher body weight and faster weight gain over time. But what comes next matters even more: the evidence doesn't show that losing weight is harder once you're on a programme, and it doesn't show that you've been doing it wrong.

PCOS has been renamed PMOS (polyendocrine metabolic ovarian syndrome), and the NHS now uses the new name. We use both here while the change beds in [1].

Here's the short answer. The 2023 international guideline and the July 2026 draft NICE guideline both recommend healthy eating and physical activity for everyone with PMOS (PCOS), whatever their weight. Both say no single diet is better than another, and the guideline notes benefits even without weight loss [2, 3]. No supplement has been proven to cause weight loss in PMOS (PCOS) either, and that includes ours.

This guide covers what the research says about why weight can be harder to manage, which approaches have trial evidence, where medicines and supplements fit, and how to track progress when the scale isn't the whole story. It's not a magic fix list. Your diagnosis is a starting point, not a verdict, and this is what I wish someone had told me years ago.

Sunlit kitchen counter with chopped vegetables, berries, eggs, wholegrain bread, lentils, trainers and a rolled yoga mat, for a guide to PMOS (PCOS) and weight

In this guide:

Is It Harder to Lose Weight With PMOS (PCOS)?

In short: Weight gain may come more easily with PMOS, but studies don't show that losing weight is harder. The evidence is small and often biased.

Let's separate two questions, because they get mixed up. Is weight gain more common in PMOS (PCOS)? Yes. Is weight loss harder once you're trying? The evidence doesn't back that up.

On gain, a meta-analysis of 35 studies and 15,129 women found that women with PMOS (PCOS) were more likely to be overweight (risk ratio 1.95), have obesity (2.77) and have central obesity (1.73) than women without it [4]. An Australian cohort of 9,145 women aged 28 to 33 found women with PMOS (PCOS) had a BMI about 2.5 kg/m² higher and gained about 2.6 kg more over 10 years [5]. A longer study followed women for 19 years and found a gain of 0.81 kg a year in women with PMOS (PCOS) against 0.55 kg a year in those without [6]. Both cohorts relied on self-reported diagnosis, and observational data can't prove cause.

Why might that happen? Insulin resistance occurs in PMOS (PCOS) regardless of weight and is made worse by excess weight [7, 8]. Barber and colleagues suggest the condition may make weight gain more likely or loss harder, through altered energy expenditure, mental ill health and inactivity, but they describe it as a hypothesis in a narrative review [9].

On loss, a systematic review of 14 weight management studies (933 participants, nine at high risk of bias) found that in the five studies that compared groups, weight loss didn't differ significantly between women with and without PMOS (PCOS) [10]. A larger comparison of a 12-week very-low-calorie diet programme matched 508 women with PMOS (PCOS) against 508 without: they lost 18.5 kg and 19.4 kg, respectively, and the difference wasn't statistically significant [11].

So what do you do with that? Treat the extra gain as a real, documented pattern, not a personal failing. And don't assume the same effort will get you less back. Your body isn't broken, and you're not doing PMOS (PCOS) wrong.

What Do the Guidelines Recommend for Weight With PMOS (PCOS)?

In short: Healthy eating and activity for everyone with PMOS, whatever their weight. No single diet is superior, and benefits can occur without weight loss.

Both main guidelines take a similar line, and it's more nuanced than 'just lose weight'.

  • The 2023 international guideline recommends lifestyle management for all individuals with PMOS (PCOS), noting benefits even without weight loss. It says there's no one superior dietary or exercise approach, that misinformation on fad diets should be refuted, and that weight-neutral care could be considered where warranted or preferred [2].
  • The draft NICE guideline (consultation closed 11 August 2026, final version expected in December 2026) says to give advice on healthy diet and physical activity regardless of BMI, to set tailored, realistic goals, and that there's no evidence any type of healthy diet is better than another, or any type or intensity of exercise [3].
  • The NHS page advises a healthy, balanced diet and regular exercise, and mentions trying to lose weight if you're overweight [1].

How much difference does lifestyle change make? A Cochrane review of 15 randomised trials (498 participants) found that lifestyle interventions lowered weight by about 1.7 kg (95% CI -2.66 to -0.70) and BMI by about 0.34 kg/m² compared with minimal or no treatment. The authors rated the evidence as low quality, and no trial reported on cycle regularity or live birth [12]. That's modest, and it's worth saying plainly.

The guideline also asks clinicians to be careful about how they talk about weight. It notes that weight stigma is common and recommends asking permission before discussing weight [2]. If you're being weighed and lectured without being listened to, you're allowed to say so. Our guide on how to advocate for yourself has scripts for that.

Which Diet Is Best for PMOS (PCOS)?

In short: No single diet is proven best. A review found weight loss helped whatever the diet, and DASH-style eating ranked best for insulin resistance.

This is the question everyone asks, and the honest answer is: nobody knows yet, and the guideline says so. A review of dietary composition in PMOS (PCOS) pulled together six articles from five studies in 137 women. Each diet showed modest, specific benefits, and weight loss improved the picture regardless of which diet produced it [13]. A later network meta-analysis of 19 trials (1,193 participants) found the DASH diet ranked best for insulin resistance, and calorie-restricted diets best for body composition [14].

Approach What the research found Caveat
Calorie reduction (any pattern) Weight loss improved presentation regardless of diet composition [13]; calorie-restricted diets ranked best for body composition [14] Small trials, mixed quality. Sustainability is not well studied
DASH or Mediterranean-style eating Both are named in the 2023 guideline [2]; DASH ranked best for insulin resistance among the diets compared [14] Ranking comes from a network comparison of mixed trials
Low-carbohydrate or low-GI eating Each showed modest, specific benefits without a clear winner [13] No evidence it beats other healthy patterns. See our insulin resistance diet guide

What helps in practice? Pick a pattern you can keep, built around mostly minimally processed food, plenty of vegetables, fibre and protein, and regular meals. That's general healthy eating advice rather than a PMOS-specific trial result, which is exactly what the guideline expects. A registered dietitian can tailor it, so it's worth asking your GP about a referral. For meal ideas, see our 7-day PMOS (PCOS) diet plan, our guide to anti-inflammatory eating and our piece on blood sugar balance.

Does Cutting Calories or Carbs Backfire With PMOS (PCOS)?

In short: Eating less does produce weight loss in PMOS. But extreme restriction carries risks, and disordered eating is more common with PMOS.

An earlier version of this article said severe calorie restriction raises cortisol and worsens insulin resistance in PMOS (PCOS). We looked for evidence and couldn't find any, so we've removed that claim. Here's what we can say instead.

Eating less can work. Trials of calorie-reduced diets in PMOS (PCOS) show weight loss and improvements in body composition and insulin resistance [13, 14]. What the research also shows is a worrying overlap with disordered eating. A 2024 meta-analysis of 20 studies (28,922 women with PMOS and 258,619 controls) found higher odds of any eating disorder (OR 1.53, 95% CI 1.29 to 1.82). The odds of bulimia and binge eating were higher, anorexia wasn't, and disordered eating scores were higher at both normal and higher BMI [15].

That's why both guidelines ask clinicians to identify and manage eating disorders, and the draft NICE guideline says not to exclude someone from care solely because of their weight [2, 3]. If you've been on and off strict diets, feel out of control around food, or binge, please tell your GP. Beat's helpline is open 3pm to 8pm on weekdays (England: 0808 801 0677) [16]. Constant dieting is a bigger risk to many people's wellbeing than the number on the scale.

So is cutting carbs a bad idea? It isn't banned, but there's no evidence it beats other healthy patterns [13]. If a plan leaves you exhausted, obsessed with food or cycling through restriction and bingeing, it isn't working for you, whatever the label says.

What Kind of Exercise Helps With PMOS (PCOS)?

In short: Exercise improves fitness, insulin markers and waist size in PMOS, but does little for the number on the scale on its own.

The 2023 guideline's adult targets mirror general advice: at least 150 minutes of moderate or 75 minutes of vigorous activity a week, plus muscle-strengthening on two non-consecutive days, with at least 250 minutes moderate or 150 vigorous for weight loss or preventing regain [2]. Those are targets to build towards, not a starting line.

What does exercise actually change? A meta-analysis of 18 trials found that exercise versus control lowered HOMA-IR (-0.57) and fasting insulin (-2.44 µIU/mL), though both came with the lowest certainty grade. It also reduced waist circumference by 2.62 cm and improved fitness (VO2max +3.84 mL/kg/min). BMI after intervention was 1.02 kg/m² lower. Exercise plus diet showed no advantage over diet alone, and the authors called the effects modest [17]. Another meta-analysis found vigorous exercise raised aerobic fitness and lowered HOMA-IR, while exercise alone had trivial effects on BMI. It suggested resistance training as a possible addition [18].

In plain English: movement helps your metabolic health and fitness even when your weight barely shifts. It's not a magic fix. Choose something you'll keep doing, whether that's walking, strength work, dancing, swimming or cycling, and build up gradually. If a routine leaves you wiped out for days, scale it back and ask a professional for help.

Do Sleep and Stress Affect Weight With PMOS (PCOS)?

In short: Sleep apnoea is more common in PMOS and can sap energy and affect weight. Ask about snoring. Stress responses may differ, but the evidence is thin.

Sleep is where a quiet, treatable problem can hide. The draft NICE guideline says obstructive sleep apnoea is common in people with PMOS regardless of BMI and recommends asking adults about symptoms [3]. A 2025 meta-analysis of eight cross-sectional studies, as summarised in its abstract, found pooled prevalence of about 37% in PMOS (PCOS) against 6% in women without it, with higher risk in those with overweight or obesity. The confidence intervals were wide, and the authors called for validation [19]. If you snore, wake unrefreshed or have daytime sleepiness, mention it to your GP. Our PMOS (PCOS) and sleep guide goes deeper.

What about stress? A small study of 32 women with PMOS (PCOS) and 32 BMI-matched controls found larger ACTH and cortisol responses to a public-speaking stressor in the PMOS group [20]. That's one study with a laboratory stressor, so it doesn't show that everyday stress causes weight gain. We didn't find evidence that stress alone drives weight in PMOS (PCOS), so we won't claim it does. Looking after your sleep and nervous system is still worth doing for its own sake.

Are Cravings in PMOS (PCOS) a Willpower Problem?

In short: Some small studies suggest hunger and fullness signals differ in PMOS, but results are mixed. Cravings aren't a character flaw.

Cravings get framed as a lack of self-control. The research is more interesting and less settled. One study found that women with PMOS (PCOS) reported less satiety and more hunger after test meals and had lower baseline ghrelin, and the authors suggested appetite regulation may be impaired [21]. A later review describes the neuroendocrine control of food intake in PMOS as altered in some reports, not as settled science [22]. In other words: some research suggests hunger and fullness signals may differ. It hasn't been proven in large studies.

What does that mean for you? Take the pressure off. Regular meals, enough protein and fibre, and not leaving long gaps are sensible habits, though we don't have PMOS-specific trials showing they quieten cravings. If you eat in secret, binge or feel out of control around food, that's worth raising with your GP rather than fixing with willpower [2].

What About Metformin and Weight-Loss Medicines?

In short: Metformin may be considered with a BMI of 25 or more, but weight benefits are marginal. Weight-loss medicines follow general obesity guidance.

Medicines are a conversation for your GP or an endocrinologist, not something to self-manage. Here's what the guidelines say:

  • Metformin. The 2023 guideline says it should be considered in adults with a BMI of 25 or above [2]. The draft NICE guideline says to consider it for metabolic health benefits, recognising that the weight loss and lipid benefits are marginal [3].
  • Anti-obesity medicines and surgery. The 2023 guideline supports them as per population guidelines, with effective contraception because pregnancy safety data are limited [2]. The draft NICE guideline points to its general obesity guidance and says not to use them to treat fertility problems, except in research [3].
  • GLP-1 receptor agonists. A 2026 meta-analysis of 11 randomised trials found a BMI reduction of 1.38 kg/m² (95% CI -2.39 to -0.38, low certainty) and no difference in HOMA-IR. The authors concluded modest short-term weight loss, with other benefits uncertain [23]. Neither guideline gives a PMOS-specific recommendation for them.

The NHS page lists weight loss medicines as an option for people who are overweight, and metformin as a medicine that can help with tiredness and weight problems [1]. If you're considering either, ask what the evidence says for someone with PMOS (PCOS), what the side effects are, and what happens when you stop.

Do Weight Loss Supplements Work for PMOS (PCOS)?

In short: No supplement has been shown to cause weight loss in PMOS. Reviews of inositol, chromium, cinnamon and others are small, mixed or inconclusive.

Let's be direct. No supplement is a fat burner, and none has been proven to cause weight loss in PMOS (PCOS). That includes ours. Here's what the research says about the ingredients you'll see in this category:

Ingredient What the research found Weight loss shown?
Myo-inositol A 2024 review for the guideline called the evidence limited and inconclusive [24]. The draft NICE guideline notes uncertainty about metabolic benefit [3]. The 2023 guideline says it may be considered per preference and that metformin should be considered over inositol for central adiposity [2] No proven effect
Chromium A review of 10 trials (683 women) found no significant BMI difference against placebo [25] No clear effect
Cinnamon A review of five small trials (206 women) found lower fasting glucose but no significant difference in BMI, weight or HOMA-IR [26] No clear effect
Alpha-lipoic acid A review of seven trials found lower fasting glucose (moderate certainty) and HOMA-IR (low certainty, very high heterogeneity), with no clear BMI difference [27] No clear effect
Green coffee bean extract Three trials in the general population (103 people) found about 1.3 kg more weight loss, low certainty, with no PMOS trial found [28] Small effect at best, not tested in PMOS
White kidney bean extract A general-population review found no significant weight difference (-1.77 kg, 95% CI -3.88 to 0.33) and called trial quality too poor for firm conclusions [29] No PMOS evidence

So where do supplements fit? Two nutrients have authorised UK claims relevant to this topic: chromium contributes to the maintenance of normal blood glucose levels, and vitamin B6 contributes to the regulation of hormonal activity, in products that are a source of those nutrients [30, 31]. Neither claim is about weight. Here are the two MyOva products people ask about, with the caveats attached.

MyOva Myoplus food supplement
Daily Food Supplement
Myoplus

4,000 mg myo-inositol with vitamin B6, which contributes to the regulation of hormonal activity, folate and chromium, which contributes to the maintenance of normal blood glucose levels. Four tablets a day.

MyOva Metabolism food supplement
Daily Food Supplement
Metabolism

2,000 mg myo-inositol with chromium, which contributes to the maintenance of normal blood glucose levels, and vitamin B6, which contributes to the regulation of hormonal activity. Also contains cinnamon, alpha-lipoic acid, green coffee bean extract, kelp, white kidney bean extract and cayenne.

Read this first. Both are food supplements, not weight loss products or treatments for PMOS (PCOS), and neither replaces advice from your GP or any prescribed medicine. As the table shows, the evidence for inositol and the botanical ingredients is limited or inconclusive. Metabolism contains kelp, a source of iodine, and green coffee bean extract, which contains caffeine, so speak to your GP first if you have a thyroid condition, take medication, or are pregnant or breastfeeding, and don't exceed the stated dose. For the bigger picture, see our guide to the best supplements for PMOS (PCOS).

Infographic titled PMOS (PCOS) and Weight with five cards: gain can be easier, loss isn't proven harder, no single best diet, movement helps, and supplements

How Do You Track Progress Without Relying on the Scale?

In short: Track things that matter to you: cycles, energy, sleep, fitness and waist, plus tests your GP arranges. Weight is one number, not the whole picture.

The guideline is clear that lifestyle change can benefit you even when weight doesn't move, and weight-neutral care is a legitimate option [2]. So build a wider scorecard:

  • Cycle changes: are periods more regular, or is your cycle diary clearer?
  • Energy and sleep: fewer afternoon crashes, better rest, less snoring or sleepiness.
  • Fitness: can you walk further, lift more or recover faster? Waist measurement also dropped in trials of exercise [17].
  • Medical checks: the 2023 guideline recommends a 75 g oral glucose tolerance test at diagnosis whatever your BMI [2]. Ask your GP how often to repeat it, and see our guide to PMOS (PCOS) and diabetes.
  • How you feel about food: less guilt, fewer rules, more regular meals.

Weight will go up and down, and that's normal. Judge change over months, not days, and keep an eye on the trend. If weight is a goal for you, you can pursue it without letting it become the only measure of whether you're doing well.

Frequently Asked Questions

Why is weight loss difficult with PMOS (PCOS)?

Weight gain tends to come more easily in PMOS (PCOS), and insulin resistance is common [4, 7]. But studies comparing women with and without PMOS haven't shown that losing weight is harder on the same programme, and the evidence is small [10].

Can I lose weight with PMOS (PCOS) without dieting?

Healthy eating and regular activity are recommended for everyone with PMOS (PCOS), and the guideline says there are benefits even without weight loss. No single diet is proven best, so focus on habits you can keep and ask about a dietitian referral [2, 3].

Do weight loss supplements work for PMOS (PCOS)?

No supplement has been proven to cause weight loss in PMOS (PCOS). Reviews of inositol, chromium, cinnamon and alpha-lipoic acid found limited or inconclusive effects on weight [24, 25, 26, 27].

Should I take metformin to lose weight?

That's a decision for you and your GP. The 2023 guideline says to consider metformin with a BMI of 25 or above, and the draft NICE guideline says its weight benefits are marginal [2, 3].

Can I be healthy without losing weight?

The guideline notes health benefits from lifestyle changes even without weight loss, and weight-neutral care can be an option. Talk to your clinician about the markers that matter for you [2].

The Bottom Line

PMOS (PCOS) is linked with easier weight gain, and that's real, but there's no good evidence that you're failing or that the same effort gets you less. The best-supported advice is also the least glamorous: healthy eating you can keep, movement you'll actually do, attention to sleep and mental health, and a clinician who treats you with respect. No supplement, including ours, is a shortcut.

Your body is trying to tell you something, and it isn't 'try harder'. Hormonal literacy isn't complicated, it's just rarely taught. Start with one change, track more than the scale, and ask for help sooner rather than later.

Related Reading

This article is for educational purposes only and does not constitute medical advice. Guidance details are accurate to the sources cited at the time of writing and may change when NICE publishes its final guideline. MyOva products are food supplements, not medicines, and are not intended to diagnose, treat, cure or prevent any disease. Food supplements should not replace a varied diet. If you think you may have PMOS (PCOS), or you are concerned about your weight or eating, speak to your GP.

References

  1. NHS. Polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS). Last reviewed 30 June 2026. https://www.nhs.uk/conditions/polyendocrine-metabolic-ovarian-syndrome-pmos/
  2. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38(9):1655-1679. doi:10.1093/humrep/dead156
  3. National Institute for Health and Care Excellence. Polycystic ovary syndrome (PMOS): draft guideline for consultation (GID-NG10436). https://www.nice.org.uk/guidance/indevelopment/gid-ng10436
  4. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-637. doi:10.1093/humupd/dms030
  5. Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526-1532. doi:10.1002/oby.20213
  6. Awoke MA, Earnest A, Joham AE, et al. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Hum Reprod. 2022;37(1):129-141. doi:10.1093/humrep/deab239
  7. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030. doi:10.1210/er.2011-1034
  8. Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95(4):531-541. doi:10.1111/cen.14421
  9. Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. doi:10.1177/1179558119874042
  10. Kataoka J, Tassone EC, Misso M, et al. Weight management interventions in women with and without PCOS: a systematic review. Nutrients. 2017;9(9):996.
  11. Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C. Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Diabetes Metab Syndr Obes. 2015;8:495-503. doi:10.2147/DMSO.S85134
  12. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;(3):CD007506. doi:10.1002/14651858.CD007506.pub4
  13. Moran LJ, Ko H, Misso M, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013;113(4):520-545. doi:10.1016/j.jand.2012.11.018
  14. Shang Y, Zhou H, Hu M, Feng H. Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105(10):dgaa425. doi:10.1210/clinem/dgaa425
  15. Cooney LG, Gyorfi K, Sanneh A, et al. Increased prevalence of binge eating disorder and bulimia nervosa in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024;109(12):3293-3305. doi:10.1210/clinem/dgae462
  16. Beat. Helplines. https://www.beateatingdisorders.org.uk/get-information-and-support/get-help-for-myself/i-need-support-now/helplines/
  17. Kite C, Lahart IM, Afzal I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev. 2019;8:51. doi:10.1186/s13643-019-0962-3
  18. Patten RK, Boyle RA, Moholdt T, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11:606. doi:10.3389/fphys.2020.00606
  19. Abdul Jafar NK, Al Balushi A, Subramanian A, et al. Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2025;16.
  20. Benson S, et al. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009;34(5):727-735.
  21. Moran LJ, Noakes M, Clifton PM, et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab. 2004;89(7):3337-3344. doi:10.1210/jc.2003-031583
  22. Romualdi D, et al. Neuroendocrine regulation of food intake in polycystic ovary syndrome. Reprod Sci. 2018;25(5):644-653.
  23. Forslund M, Wändell P, Forsberg L, et al. GLP-1 receptor agonist treatment in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol. 2026;194(3):S25-S39. doi:10.1093/ejendo/lvag033
  24. Fitz V, Graca S, Mahalingaiah S, et al. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines. J Clin Endocrinol Metab. 2024;109(6):1630-1655. doi:10.1210/clinem/dgad762
  25. Hamsho M, Ranneh Y, Fadel A. Endocrinol Diabetes Nutr. 2025;72(8). doi:10.1016/j.endien.2025.501578
  26. Wahyuningtyas R, Sa'adi A. F1000Research. 2021;10:523.
  27. Abu-Zaid A, et al. Obstet Gynecol Sci. 2024;67(1):17-29. doi:10.5468/ogs.23206
  28. Kanchanasurakit S, Saokaew S, Phisalprapa P, Duangjai A. Syst Rev. 2023;12:163. doi:10.1186/s13643-023-02311-4
  29. Onakpoya I, Aldaas S, Terry R, Ernst E. The efficacy of Phaseolus vulgaris as a weight-loss supplement: a systematic review and meta-analysis of randomised clinical trials. Br J Nutr. 2011;106(2):196-202. doi:10.1017/S0007114511001516
  30. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the substantiation of health claims related to chromium. EFSA Journal. 2010;8(10):1732. doi:10.2903/j.efsa.2010.1732
  31. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the substantiation of health claims related to vitamin B6. EFSA Journal. 2009;7(9):1225.
Leila Martyn

Leila Martyn

Leila is the founder of MyOva, a UK-based hormonal health brand for women with PMOS (PCOS), endometriosis, perimenopause, PMDD and fertility challenges. Drawing on lived experience and scientific research, she shares evidence-based guidance to help women feel informed about their hormones and cycles.

Discover your perfect product in under a minute!

Take our quiz & get 20% off

References